GORDON CARL L
CIK 1282930
Transactions on file
46
Open-market buys
27
Win rate (buys)
93%
27 scored
Avg % since filing (buys)
+74.3%
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-11-11 | 2026-11-10 | ETRA Electra Therapeutics, Inc. | Director10% | Buy | 2,000 | $16.9K | +4.6% | open → |
| 2026-11-11 | 2026-11-10 | ETRA Electra Therapeutics, Inc. | Director10% | Buy | 20,700 | $174.9K | +4.6% | open → |
| 2026-11-11 | 2026-11-09 | ETRA Electra Therapeutics, Inc. | Director10% | Buy | 16,000 | $131.8K | +7.3% | open → |
| 2026-11-11 | 2026-11-09 | ETRA Electra Therapeutics, Inc. | Director10% | Buy | 4,000 | $33.0K | +7.3% | open → |
| 2026-11-11 | 2026-11-06 | ETRA Electra Therapeutics, Inc. | Director10% | Buy | 39,600 | $310.9K | +12.6% | open → |
| 2026-11-11 | 2026-11-06 | ETRA Electra Therapeutics, Inc. | Director10% | Buy | 9,816 | $77.1K | +12.6% | open → |
| 2026-11-05 | 2026-11-05 | ETRA Electra Therapeutics, Inc. | Director10% | Buy | 125,200 | $915.2K | +20.9% | open → |
| 2026-11-05 | 2026-11-05 | ETRA Electra Therapeutics, Inc. | Director10% | Buy | 30,891 | $225.8K | +20.9% | open → |
| 2026-11-05 | 2026-11-04 | ETRA Electra Therapeutics, Inc. | Director10% | Buy | 20,000 | $141.4K | +25.0% | open → |
| 2026-11-05 | 2026-11-04 | ETRA Electra Therapeutics, Inc. | Director10% | Buy | 5,000 | $35.4K | +25.0% | open → |
| 2026-11-05 | 2026-11-04 | ETRA Electra Therapeutics, Inc. | Director10% | Buy | 37,100 | $288.6K | +13.6% | open → |
| 2026-11-05 | 2026-11-04 | ETRA Electra Therapeutics, Inc. | Director10% | Buy | 9,267 | $72.1K | +13.6% | open → |
| 2026-11-05 | 2026-11-03 | ETRA Electra Therapeutics, Inc. | Director10% | Buy | 98,600 | $777.0K | +12.2% | open → |
| 2026-11-05 | 2026-11-03 | ETRA Electra Therapeutics, Inc. | Director10% | Buy | 24,400 | $192.3K | +12.2% | open → |
| 2026-11-05 | 2026-11-03 | ETRA Electra Therapeutics, Inc. | Director10% | Buy | 97,800 | $766.8K | +12.8% | open → |
| 2026-11-05 | 2026-11-03 | ETRA Electra Therapeutics, Inc. | Director10% | Buy | 24,313 | $190.6K | +12.8% | open → |
| 2026-09-30 | 2026-09-28 | ADRX ADARx Pharmaceuticals, Inc. | Director10% | Buy | 588,235 | $10.00M | +5.0% | open → |
| 2026-09-30 | 2026-09-28 | ADRX ADARx Pharmaceuticals, Inc. | Director10% | Buy | 61,516 | $1.05M | +5.0% | open → |
| 2026-09-30 | 2026-09-28 | ADRX ADARx Pharmaceuticals, Inc. | Director10% | C | 256,448 | $0.00 | — | open → |
| 2026-09-30 | 2026-09-28 | ADRX ADARx Pharmaceuticals, Inc. | Director10% | C | 513,067 | $0.00 | — | open → |
| 2026-09-30 | 2026-09-28 | ADRX ADARx Pharmaceuticals, Inc. | Director10% | C | 1,333,975 | $0.00 | — | open → |
| 2026-09-30 | 2026-09-28 | ADRX ADARx Pharmaceuticals, Inc. | Director10% | C | 7,127,019 | $0.00 | — | open → |
| 2026-09-30 | 2026-09-28 | ADRX ADARx Pharmaceuticals, Inc. | Director10% | Buy | 300,249 | $5.10M | +5.0% | open → |
| 2026-09-30 | 2026-09-28 | ADRX ADARx Pharmaceuticals, Inc. | Director10% | C | 564,187 | $0.00 | — | open → |
| 2026-09-30 | 2026-09-28 | ADRX ADARx Pharmaceuticals, Inc. | Director10% | C | 769,601 | $0.00 | — | open → |
| 2026-09-30 | 2026-09-28 | ADRX ADARx Pharmaceuticals, Inc. | Director10% | C | 2,000,962 | $0.00 | — | open → |
| 2026-09-30 | 2026-09-28 | ADRX ADARx Pharmaceuticals, Inc. | Director10% | C | 10,690,530 | $0.00 | — | open → |
| 2026-09-23 | 2026-09-21 | ETRA Electra Therapeutics, Inc. | Director10% | Buy | 1,000,000 | $15.00M | -41.1% | open → |
| 2026-09-23 | 2026-09-21 | ETRA Electra Therapeutics, Inc. | Director10% | C | 758,279 | $0.00 | — | open → |
| 2026-09-23 | 2026-09-21 | ETRA Electra Therapeutics, Inc. | Director10% | Buy | 333,333 | $5.00M | -41.1% | open → |
| 2026-09-23 | 2026-09-21 | ETRA Electra Therapeutics, Inc. | Director10% | C | 1,703,314 | $0.00 | — | open → |
| 2026-09-23 | 2026-09-21 | ETRA Electra Therapeutics, Inc. | Director10% | C | 1,087,934 | $0.00 | — | open → |
| 2026-09-23 | 2026-09-21 | ETRA Electra Therapeutics, Inc. | Director10% | C | 2,002,310 | $0.00 | — | open → |
| 2026-08-12 | 2026-08-10 | BLSM BlossomHill Therapeutics, Inc. | Director | Buy | 625,000 | $10.00M | +34.4% | open → |
| 2026-08-12 | 2026-08-10 | BLSM BlossomHill Therapeutics, Inc. | Director | C | 1,049,283 | $0.00 | — | open → |
| 2026-08-12 | 2026-08-10 | BLSM BlossomHill Therapeutics, Inc. | Director | C | 1,039,996 | $0.00 | — | open → |
| 2026-07-29 | 2026-07-27 | SCTX Scribe Therapeutics, Inc. | Director | Buy | 1,000,000 | $15.00M | +111.3% | open → |
| 2026-07-29 | 2026-07-27 | SCTX Scribe Therapeutics, Inc. | Director | C | 348,825 | $0.00 | — | open → |
| 2025-02-19 | 2025-02-18 | MBX MBX Biosciences, Inc. | Director10% | Buy | 94,100 | $1.02M | +402.9% | open → |
| 2025-02-19 | 2025-02-14 | MBX MBX Biosciences, Inc. | Director10% | Buy | 17,962 | $177.8K | +450.6% | open → |
| 2025-02-19 | 2025-02-14 | MBX MBX Biosciences, Inc. | Director10% | Buy | 29,540 | $291.0K | +453.4% | open → |
| 2025-02-19 | 2025-02-18 | MBX MBX Biosciences, Inc. | Director10% | Buy | 49,070 | $531.9K | +402.9% | open → |
| 2025-04-11 | 2025-04-09 | CMPX Compass Therapeutics, Inc. | Director10% | Sale | 3,571,428 | $5.68M | -50.5% | open → |
| 2025-06-06 | 2025-06-04 | KROS Keros Therapeutics, Inc. | Director | Grant | 5,250 | $0.00 | — | open → |
| 2025-12-18 | 2025-11-21 | KROS Keros Therapeutics, Inc. | Director | Disp. | 74,465 | $1.32M | -37.0% | open → |
| 2025-12-18 | 2025-11-21 | KROS Keros Therapeutics, Inc. | Director | Disp. | 140,057 | $2.49M | -37.0% | open → |
